Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
Completed
Axovant Sciences Ltd.
Phase 3
This study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an
adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.
12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
Terminated
Axovant Sciences Ltd.
Phase 3
This 12-month open-label study will provide further information regarding the long-term
safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who
have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind
study).
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
Completed
Axovant Sciences Ltd.
Phase 2
This study seeks to evaluate the effect of intepirdine (RVT-101) on gait and balance in
patients with Alzheimer's Disease, Dementia with Lewy Bodies or Parkinson's Disease Dementia.
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
Terminated
Axovant Sciences Ltd.
Phase 2/Phase 3
This 6-month extension study will provide further information regarding the long-term safety
and tolerability of intepirdine (RVT-101) in subjects with Dementia with Lewy bodies (DLB)
who have participated in the double-blind, placebo-controlled, lead-in study RVT-101-2001.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
